Sale!

VISTOGARD Drug Profile, 2024

Original price was: $800.00.Current price is: $399.00.

VISTOGARD (uridine triacetate) drug patents, SPCs, suppliers, API sources

SKU: VISTOGARD Category:
Originally published at https://www.chemintel360.com/. Get our excipient business reports at https://chemintel360.com/product-category/excipients/, and our drug patent reports at https://chemintel360.com/product-category/drug-patent-reports/

VISTOGARD Drug Profile, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs.

This definitive guide provides invaluable business insights into every crucial aspect of this medication, addressing the vital points necessary to make business decisions.

Gain key critical insights for VISTOGARD:

  • United States patents
  • Expired United States patents
  • European supplementary protection certificates (SPCs)
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources
Pages

28

Product

VISTOGARD

ChemIntel360
Scroll to Top